3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
9
Neoplasms
7
Anxiety Disorders
6
Depression
3
Ovarian Neoplasms
2
Chronic Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Tendinopathy
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sarcoma
1
Radiculopathy
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Pathophobia
1
Pain, Postoperative
1
Pain
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Nausea
1
Myocarditis
1
Musculoskeletal Pain
1
Melanoma
1
Medication Adherence
1
Lung Diseases, Interstitial
1
Leukemia, Myeloid, Acute
1
Hot Flashes
1
Interventions
Ifosfamide
12
Filgrastim
12
Carboplatin
12
Peripheral Blood Stem Cell Transplantation
11
Etoposide
11
Paclitaxel
9
Cyclophosphamide
7
Cisplatin
6
Thiotepa
4
Flow Cytometry
4
Radiotherapy
3
Immunologic Techniques
3
pegfilgrastim
2
etoposide phosphate
2
Vinblastine
2
Temozolomide
2
Microarray Analysis
2
Methylprednisolone
2
Busulfan
2
Alemtuzumab
2
guadecitabine
1
fludarabine phosphate
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Topotecan
1
Tacrolimus
1
Sunitinib
1
Psychiatric Rehabilitation
1
Prednisone
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Testicular Germ Cell Tumor
×
Hypnosis
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled